Americans now say they approve of free trade by 64%-27%, a margin of better than two to one. That's up from 57%-37% early in Trump's presidency, and 51%-41% near the end of...Politicsread more
CNBC combed through Wall Street research to see which stocks are still a buy after their earnings reports.Marketsread more
Fraud investigator Harry Markopolos' accusations extended beyond GE's management to actuaries, auditors and analysts who he claims overlooked billions in liabilities.Marketsread more
Bianco Research's James Bianco suggests Wall Street is desperately looking for a signal that a 50 basis point cut is coming next month.Trading Nationread more
The company's S-1 lays the groundwork for what is widely expected to be one of the largest initial public offerings of the year, second only to Uber's IPO in May. It's also...Technologyread more
President Donald Trump held a call on Wednesday with the CEOs of three major U.S. banks, according to people with knowledge of the situation.Marketsread more
Despite aggressive strides, Waymo needs one thing before their self-driving cars become a seriously useful transportation system: people. We talked to the ones closest to it.Technologyread more
Trump's tweet comes a day after Apple put out a press release describing the money it spends on U.S.-based suppliers and vendors.Technologyread more
Scientists say the smoke plumes, filled with megatons of tiny, harmful particles, could travel to other areas of the world and cause serious respiratory problems for people.Weather & Natural Disastersread more
Some Weight Watchers loyalists applaud Kurbo by WW. But nutritionists worry Kurbo promotes an unhealthy relationship with food during an especially impressionable time.Health and Scienceread more
Benefits from what President Trump called "the biggest reform of all time" to the tax code have dwindled to a faint breeze just 20 months after its enactment, writes John...Politicsread more
The drugstore operator also announced it would start next-day delivery from its stores in 2018, a move some analysts are saying comes in response to Amazon's encroaching presence within the space.
"We will bring the pharmacy to our patients' doorsteps," Chief Executive Larry Merlo said on a call with analysts and investors.
Meantime, CVS is in talks to buy health insurer Aetna for a proposed $200 per share or more, sources familiar with the matter say. The potential deal comes as CVS moves further into health care amid increasing pressure on its traditional retail sales.
CVS reported net revenue of $46.18 billion, up 3.5 percent from the same quarter last year, and essentially in line with Thomson Reuters estimates.
In the third quarter, CVS said its net income fell to $1.29 billion, or $1.26 per share, from $1.54 billion, or $1.43 a share, a year earlier.
Excluding items, the company earned $1.50 per share, outpacing Wall Street estimates of $1.48 per share.
The Woonsocket, Rhode Island-based company has been transforming itself into a health-care business for years, propelled by its acquisition of the Caremark pharmacy benefit manager platform in 2007. (A PBM typically is a third party that negotiates prescription drug benefits for a commercial health plan.)
It generated net sales of $32.9 billion for its PBM business for the quarter — roughly 70 percent of its sales — up 8.1 percent from the quarter before. Profitability in the division though was hurt by pressure on drug prices.
An acquisition of an insurer like Aetna could give CVS greater bargaining power with drug companies.
Sales of cosmetics and household goods, CVS' "front of store" business, meanwhile dropped 2.8 percent. CVS increasingly faces competition for these goods from big-box stores and grocers, sometimes for a lower price.
Amazon's potential move into selling prescription drugs online adds further threat, because shoppers would be less likely to go to CVS to pick up their medications, and thus other household goods.
The Seattle giant also recently launched "Discount provided by Amazon" promotions, in which it slashes prices on third-party goods it is selling, in order to meet or beat the prices of its rivals like Wal-Mart.
CVS narrowed and raised the midpoint of the range for full-year adjusted earnings per share from $5.87 to $5.91. Including the charges due to hurricanes, from $5.83 to $5.93.